Fat mass and obesity-associated gene expression and disease severity in type 2 diabetes mellitus.
Fat-mass and obesity-associated gene
Insulin resistance
Obesity
Type2diabetes mellitus
Journal
Steroids
ISSN: 1878-5867
Titre abrégé: Steroids
Pays: United States
ID NLM: 0404536
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
30
11
2020
revised:
08
05
2021
accepted:
20
07
2021
pubmed:
7
8
2021
medline:
25
2
2022
entrez:
6
8
2021
Statut:
ppublish
Résumé
Obesity and visceral adiposity are major risk factors for type 2 diabetes mellitus (T2DM). The fat mass and obesity-associated (FTO) gene is associated with increased risk of obesity and T2DM. The aim of this work was to study the association between FTO gene expression and serum FTO protein level with disease severity in T2DM patients. One hundred T2DM patients were divided into two equal groups according to diabetes control and complications and fifty healthy controls were included in this study. FTO messenger ribonucleic acid (mRNA) expression level was analyzed by Real time polymerase chain reaction (PCR) technique and serum level of FTO protein was measured by ELISA. FTO gene expression and FTO protein levels were increased in the two T2DM groups compared to the control group with significant further increases in patients with severe disease. FTO gene expression and FTO protein levels were positively correlated with obesity, insulin resistance and blood glucose indices as well as the presence of diabetic complications. Regression analyses showed that FTO gene expression and FTO protein levels were risk factors for T2DM severity. Increased FTO gene expression and its serum protein levels are associated with increased T2DM severity.
Identifiants
pubmed: 34358558
pii: S0039-128X(21)00109-4
doi: 10.1016/j.steroids.2021.108897
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108897Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.